Publication | Closed Access
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
772
Citations
23
References
2018
Year
OncologyPathologyBronchial NeoplasmGlobal Phase 2Cancer TreatmentMedicineRadiation OncologyLung CancerCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1